Inventor · disambiguated record
Jared Lunceford
Also filed as: LUNCEFORD JARED · LUNCEFORD JARED K
2 granted patents·6 pending applications·0 citations·filing 2014–2022
21Inventor score
Top patents by PatentIndex Score
8 records- 0148US2025044295A1Biomarkers for predicting eligibility for an anti-ilt4 and anti-pd-1 combination therapyMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 0248US2022380854A1ANGIOGENESIS AND mMDSC GENE EXPRESSION BASED BIOMARKER OF TUMOR RESPONSE TO PD-1 ANTAGONISTSMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 0346US2016312297A1Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 0445US2022112564A1Gene expression based biomarker of tumor response to pd-1 antagonistsLOBODA ANDREY·Filed 2020·Application pending·0 cites
- 0544US2016312295A1Gene signature biomarkers of tumor response to pd-1 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 0644US2016304969A1Ifn-gamma gene signature biomarkers of tumor response to pd-1 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 0742US11326211B2Blood-based biomarkers of tumor sensitivity to PD-1 antagonistsMERCK SHARP & DOHME·Filed 2016·Granted May 10, 2022·0 cites·18 claims
- 0827US11377693B2System and methods for deriving gene signature biomarkers of response to PD-1 antagonistsAYERS MARK D·Filed 2015·Granted Jul 5, 2022·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Jared Lunceford files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →